Exegenesis Bio
Lansdale
About Exegenesis Bio
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2021)
- Website: exegenesisbio.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/exegenesis-bio-94249 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.